583
Participants
Start Date
May 31, 2007
Primary Completion Date
December 31, 2010
Study Completion Date
January 31, 2011
Zonisamide
Week 1 and 2 either 100mg zonisamide or 200 mg carbamazepine Week 3 and 4 either 200mg zonisamide or 4800 mg carbamazepine Week 5 and 6 either 300mg zonisamide or 600 mg carbamazepine; this dose then to be maintained unless a subject has a seizure more than two weeks post a dose increase.
Carbamazepine
Week 1 and 2 either 100mg zonisamide or 200 mg carbamazepine Week 3 and 4 either 200mg zonisamide or 4800 mg carbamazepine Week 5 and 6 either 300mg zonisamide or 600 mg carbamazepine; this dose then to be maintained unless a subject has a seizure more than two weeks post a dose increase.
Camperdown
Clayton
Fitzroy
Flinders
Heidelberg West
Parkville
Queensland
Wellington
Aalborg
Béthune
Dijon
Paris
Saint-Etienne
Berlin
Bochum
Düsseldorf
Munich
Schwerin
Westerstede
Athens
Thessaloniki
Budapest
Debrecen
Gyula
Hódmezővásárhely
Nyregyhaza
Zalaegerszeg-Pozva
Bangalore
Hyderabad
Koturpuram
Madurai
New Delhi
Pune
Milan
Monza
Orbassano
Rome
Gdansk
Katowice
Krakow
Lodz
Lublin
Poznan
Sosnowiec
Szcecin
Warsaw
Kaliningrad
Kazan'
Moscow
Saint Petersburg
Yaroslavl
Belgrade
Niš
Novi Sad
Subotica
Bratislava
Bratslava
Brezno
Nové Zámky
Vranov nad Topľou
Žilina
Sandton
Anyang
Seoul
Wŏnju
Alicante
Bacelona
Barcelona
Madrid
Málaga
Oviedo
Seville
Gothenburg
Lund
Changhua
Yongkang District
Bristol
Liverpool
Treliske
Eisai Inc.
INDUSTRY